BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time
BioHarvest Sciences (NASDAQ: BHST), a pioneer in Botanical Synthesis technology, will release its Q1 2025 financial results on May 15, 2025, after market close. The company will host an investor conference call and webcast at 4:30 p.m. Eastern time on the same day.
Management will discuss quarterly results, provide a corporate update, and hold a Q&A session. The conference call can be accessed via U.S./Canada dial-in (1-877-300-8521) or International dial-in (1-412-317-6026) using Conference ID 2552254. A telephone replay will be available through May 29, 2025.
BioHarvest Sciences (NASDAQ: BHST), pioniere nella tecnologia di Sintesi Botanica, pubblicherà i suoi risultati finanziari del primo trimestre 2025 il 15 maggio 2025, dopo la chiusura del mercato. La società terrà una conference call per gli investitori e una webcast alle 16:30 ora della costa orientale dello stesso giorno.
Il management discuterà i risultati trimestrali, fornirà un aggiornamento aziendale e risponderà alle domande durante una sessione Q&A. La conference call sarà accessibile tramite chiamata dagli Stati Uniti/Canada (1-877-300-8521) o dall’estero (1-412-317-6026) utilizzando il codice Conference ID 2552254. La registrazione telefonica sarà disponibile fino al 29 maggio 2025.
BioHarvest Sciences (NASDAQ: BHST), pionera en tecnología de Síntesis Botánica, publicará sus resultados financieros del primer trimestre de 2025 el 15 de mayo de 2025, después del cierre del mercado. La empresa realizará una llamada de conferencia para inversores y una transmisión por internet a las 4:30 p.m., hora del Este del mismo día.
La dirección discutirá los resultados trimestrales, ofrecerá una actualización corporativa y llevará a cabo una sesión de preguntas y respuestas. La llamada se puede acceder mediante marcación en EE.UU./Canadá (1-877-300-8521) o internacional (1-412-317-6026) usando el ID de conferencia 2552254. La repetición telefónica estará disponible hasta el 29 de mayo de 2025.
BioHarvest Sciences (NASDAQ: BHST)는 식물 합성 기술의 선구자로서 2025년 1분기 재무 실적을 2025년 5월 15일 장 마감 후 발표할 예정입니다. 같은 날 오후 4시 30분(동부 시간)에 투자자 컨퍼런스 콜과 웹캐스트를 진행합니다.
경영진은 분기 실적을 논의하고 회사 현황을 업데이트하며 질의응답 시간을 가질 예정입니다. 컨퍼런스 콜은 미국/캐나다 내 전화(1-877-300-8521) 또는 국제 전화(1-412-317-6026)에서 회의 ID 2552254를 사용하여 접속할 수 있습니다. 전화 녹음은 2025년 5월 29일까지 제공됩니다.
BioHarvest Sciences (NASDAQ : BHST), pionnier de la technologie de synthèse botanique, publiera ses résultats financiers du premier trimestre 2025 le 15 mai 2025, après la clôture du marché. La société organisera une conférence téléphonique pour les investisseurs et une diffusion en webcast à 16h30, heure de l’Est le même jour.
La direction présentera les résultats trimestriels, fournira une mise à jour de l’entreprise et tiendra une session de questions-réponses. La conférence téléphonique est accessible par téléphone aux États-Unis/Canada (1-877-300-8521) ou à l’international (1-412-317-6026) avec l’ID de conférence 2552254. La rediffusion téléphonique sera disponible jusqu’au 29 mai 2025.
BioHarvest Sciences (NASDAQ: BHST), ein Pionier der Botanischen Synthesetechnologie, wird seine Finanzergebnisse für das erste Quartal 2025 am 15. Mai 2025 nach Börsenschluss veröffentlichen. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz und einen Webcast für Investoren abhalten.
Das Management wird die Quartalsergebnisse besprechen, ein Unternehmensupdate geben und eine Fragerunde durchführen. Die Telefonkonferenz ist über die Einwahlnummern für USA/Kanada (1-877-300-8521) oder international (1-412-317-6026) mit der Konferenz-ID 2552254 erreichbar. Eine Telefonaufzeichnung ist bis zum 29. Mai 2025 verfügbar.
- None.
- None.
Rehovot, Israel--(Newsfile Corp. - May 1, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the first quarter ended March 31, 2025 after market close on Thursday, May 15, 2025.
Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on Thursday, May 15, 2025 to discuss the Company's first quarter 2025 financial results, provide a corporate update, and conclude with a question-and-answer session from telephone participants. To participate, please use the following information:
First Quarter 2025 Earnings Conference Call
Date: Thursday, May 15, 2025
Time: 4:30 p.m. Eastern time
U.S./Canada Dial-in: 1-877-300-8521
International Dial-in: 1-412-317-6026
Conference ID: 2552254
Webcast: BHST Q1 2025 Earnings Conference Call
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
A telephone playback of the call will be available through Thursday, May 29, 2025. To listen, call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 10198733. A webcast replay will also be available at the webcast link above.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHST@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250433
FAQ
When will BioHarvest Sciences (BHST) release its Q1 2025 earnings?
What time is BioHarvest Sciences (BHST) Q1 2025 earnings call?
How can I join BioHarvest Sciences (BHST) Q1 2025 earnings call?
Until when will BioHarvest Sciences (BHST) Q1 2025 earnings call replay be available?
